A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19

B Thakur, P Dubey, J Benitez, JP Torres, S Reddy… - Scientific reports, 2021 - nature.com
Several comorbidities have been shown to be associated with coronavirus disease 2019
(COVID-19) related severity and mortality. However, considerable variation in the …

COVID–19 and chronic kidney disease: an updated overview of reviews

SS Jdiaa, R Mansour, A El Alayli, A Gautam… - Journal of …, 2022 - Springer
Abstract Background Coronavirus disease (COVID–19) has resulted in the death of more
than 3.5 million people worldwide. While COVID–19 mostly affects the lungs, different …

Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study

W Jassat, C Cohen, S Tempia, M Masha… - The Lancet …, 2021 - thelancet.com
Background The interaction between COVID-19, non-communicable diseases, and chronic
infectious diseases such as HIV and tuberculosis is unclear, particularly in low-income and …

Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence

M Treskova-Schwarzbach, L Haas, S Reda, A Pilic… - BMC medicine, 2021 - Springer
Background This study applies an umbrella review approach to summarise the global
evidence on the risk of severe COVID-19 outcomes in patients with pre-existing health …

Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies

Y Mahamat-Saleh, T Fiolet, ME Rebeaud, M Mulot… - BMJ open, 2021 - bmjopen.bmj.com
Objectives We conducted a systematic literature review and meta-analysis of observational
studies to investigate the association between diabetes, hypertension, body mass index …

Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study

E Ge, Y Li, S Wu, E Candido, X Wei - PLoS One, 2021 - journals.plos.org
Background The novel coronavirus disease 2019 (COVID-19) has infected 1.9% of the world
population by May 2, 2021. Since most previous studies that examined risk factors for …

Covid-19 and non-communicable diseases: evidence from a systematic literature review

Z Nikoloski, AM Alqunaibet, RA Alfawaz… - BMC Public Health, 2021 - Springer
Abstract Background Since early 2020, the Covid-19 pandemic has engulfed the world.
Amidst the growing number of infections and deaths, there has been an emphasis of …

Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901: interim results of a large-scale …

SM Hsieh, MC Liu, YH Chen, WS Lee… - The Lancet …, 2021 - thelancet.com
Background MVC-COV1901, a recombinant protein vaccine containing pre-fusion-stabilised
spike protein S-2P adjuvanted with CpG 1018 and aluminium hydroxide, has been shown to …

[PDF][PDF] Evaluation of COVID-19 vaccine effectiveness: interim guidance, 17 March 2021

World Health Organization - 2021 - apps.who.int
Since its emergence in December 2019, SARS-CoV-2, the virus that causes coronavirus
disease 2019 (COVID-19), has taken a tremendous toll globally; by 28 February 2021, there …

Oral nano‐curcumin formulation efficacy in management of mild to moderate hospitalized coronavirus disease‐19 patients: An open label nonrandomized clinical trial

N Saber‐Moghaddam, S Salari, S Hejazi… - Phytotherapy …, 2021 - Wiley Online Library
Curcumin is proposed as a potential treatment option for coronavirus disease‐19 (COVID‐
19) by inhibiting the virus entrance, encapsulation and replication, and modulating various …